What We're Reading: Page 220
Industry reads hand-picked by our editors
Jan 07, 2020
Jan 06, 2020
Jan 03, 2020
-
The Wall Street Journal
FDA’s Deadline Problem?
-
FiercePharma
Regeneron to lay off field staffers as it restructures Sanofi partnership
-
Bloomberg
Carcinogen in Zantac May Build During Storage, Lab Finds
-
Reuters
Novo Nordisk to offer free insulin to U.S. patients in immediate need
Jan 02, 2020
-
The New York Times
As Tens of Thousands Died, F.D.A. Failed to Police Opioids
-
MIT Technology Review
He Jiankui faces three years in prison for CRISPR babies
-
Reuters
Study finds Google system could improve breast cancer detection
Dec 23, 2019
-
ProPublica
Doctors Prescribe More of a Drug If They Receive Money from a Pharma Company Tied to It
-
Bloomberg
Year’s Best U.S. IPO Is a Little-Known Biotech With 420% Surge
-
The Wall Street Journal
A Genetic Test Led Seven Women in One Family to Have Major Surgery. Then the Odds Changed.
-
Endpoints News
Eisai scores an FDA approval for a homegrown sleep drug
Dec 20, 2019
-
The Wall Street Journal
Novartis to Offer World’s Most Expensive Drug for Free Via Lottery
-
STAT
Waning treatment is a warning for all 'one-and-done' therapies
-
S&P Global
Lawmakers seek to loosen US FDA drug approval requirements to allow early access
-
C&EN
An oral form of a blockbuster diabetes drug has arrived. Will people be able to get it?
Previous
